ADXS-HPV: Phase I/II started

Advaxis said investigators at the Icahn School of Medicine at Mount Sinai began an open-label, U.S. Phase I/II trial to compare 2 vaccinations of IV ADXS-HPV followed by ablative transoral robotic su...